drugset / Trial / NCT00856271

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

NCT00856271

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of olmesartan medoxomil compared with losartan potassium in patients with mild to moderate essential hypertension.

Timeline

Start
2004-08
Primary completion
2005-02
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Losartan Other / unclassified Oral
Subject Olmesartan medoxomil Unknown Oral